This new referral pathway is part of a research pilot project that aims to support patients and primary health care providers by facilitating access to care and information related to lung nodules and lung cancer screening.

Key points

  • This pilot project will run from July 2025 to June 2026
  • Healthcare providers must provide patients with a copy of our participant opt-out information sheet at the time of referral to our program. The sheet will also be sent to patients who are attending clinic appointments with their appointment correspondence
  • Patients who decline participation in this pathway should be referred via our existing Respiratory Outpatient Clinic referral pathway stating they have declined the lung nodule and lung cancer screening pathway
  • Referring healthcare providers can contact our lung nodule and lung cancer screening nurse hotline for telephone and email advice

What we do

This pilot research project has a streamlined referral process that will allow patients and primary healthcare providers to access the following resources:

  • Dedicated lung nodule and lung cancer screening nurse support (via telephone and email) for referring healthcare providers
  • Streamlined non-screen detected lung nodule clinics
  • Streamlined lung cancer screening high-risk findings clinics with a respiratory physician linked to a multidisciplinary team (as recommended by low dose computed tomography (LDCT) screening report)
  • Streamlined lung cancer screening-detected respiratory additional finding (as recommended by LDCT screening report)

The streamlined referral pathway is part of a pilot project that will run from July 2025 to June 2026. It is funded by the Victorian Medical Research Acceleration Fund and the Royal Melbourne Hospital Foundation.

For patients
For health professionals

Need to change or cancel your appointment?

Do one of the following:

About the National Lung Cancer Screening Program

The RMH is proud to support the National Lung Cancer Screening Program (NLCSP) as part of Victoria’s network of public lung nodule clinics. These clinics play a vital role in the early detection and management of lung cancer, supporting the assessment and early management of patients with high-risk screening results.

The NLCSP is a free, Commonwealth-funded program designed to detect lung cancer early, when treatment is more effective and survival rates are higher. Eligible community members can be referred for a screening test (low dose CT) at a participating radiology provider by their GP.

To be eligible, individuals must:

  • be aged between 50 and 70 years
  • be asymptomatic (no signs or symptoms of lung cancer)
  • currently smoke or have quit within the past 10 years
  • have a history of tobacco cigarette smoking of at least 30 pack-years.
Last updated 08 July 2025